CENOS St Jude retweeted
Excited to see our study published in the October issue of Nature Genetics! 🎉 nature.com/articles/s41588-0…
We characterized the chromatin landscapes across medulloblastoma (MB) subgroups and identified KDM2B as a selective dependency in Group 3/4 tumors. 1/5
CENOS St Jude retweeted
Applications are now open to join the St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences, preparing students to be leaders who transform healthcare outcomes worldwide. Apply today: ow.ly/MsOq50WWYeN
CENOS St Jude retweeted
Ependymoma, the third most common childhood brain tumor, has seen little therapeutic progress in 30+ years. New findings reveal how the ZFTA–RELA fusion protein drives tumor formation via condensates. ow.ly/fg4r50WMPZJ
CENOS St Jude retweeted
We are excited to kick off this season of SOCC with a milestone: our 150th lecture. Join us every Thursday, from 8/14 to 11/20, at 12 PM CT / 1 PM ET for an engaging and interactive 15-week virtual lecture series.
CENOS St Jude retweeted
A deeper understanding of how cells organize themselves is changing the way we think about neurological diseases. At St. Jude, researchers are studying biomolecular condensates—droplets that organize proteins, RNA and DNA—to uncover new treatment strategies.
CENOS St Jude retweeted
Online Now: Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis dlvr.it/TKtj2P
CENOS St Jude retweeted
Online Now: Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target dlvr.it/TKtvlP
CENOS St Jude retweeted
New research reveals how ELP1 germline deficiency predisposes children to SHH-medulloblastoma and identifies a promising targeted therapy: MDM2 inhibitors. These findings may form the basis for adding MDM2 inhibition to clinical trials for SHH-medulloblastoma.
CENOS St Jude retweeted
Share this post to raise awareness for kids with brain tumors and donate today to support pediatric brain tumor research! 🎗️
Brain tumors are the deadliest form of childhood cancer in the United States, accounting for a third of all pediatric cancer deaths each year. Each of us can make a difference for children battling brain tumors by spreading awareness and working to fund groundbreaking research happening right now.
Read the facts you need to know about pediatric brain tumors and how you can help kids>
alexslemonade.org/blog/eight…
CENOS St Jude retweeted
Today is #WorldCancerDay, and St. Jude is as committed as ever to fighting childhood cancer on all fronts. Danny Thomas said, “No child should die in the dawn of life.”
CENOS St Jude retweeted
Thrilled to share our recent work published in @NatureGenet, where we uncover how ZIC1 is regulated by distinct genetic and epigenetic mechanisms in SHH vs. Group 4 medulloblastoma—revealing it as a context-dependent driver. Huge thanks to the collaboration between Taylor, @drpaulnorthcott, and Huang labs. tinyurl.com/2c3jnhn2 @SJCENOS @StJudeResearch
CENOS St Jude retweeted
When St. Jude opened in 1962, childhood cancer was largely considered incurable. Since then, St. Jude has helped push the overall survival rate from 20% to more than 80%, and we won't stop until no child dies from cancer.
But we can't do it without you!
CENOS St Jude retweeted
NCI-supported scientists @bcmhouston and @StJudeResearch recently found that an epigenetic modification involving serotonin (a substance that nerves use to send messages to one another) may drive the growth of a rare #BrainTumor in children. go.nih.gov/1YKLXv2 #BTSM
CENOS St Jude retweeted
Nature research paper: Histone serotonylation regulates ependymoma tumorigenesis go.nature.com/3WsgDXm















